Literature DB >> 11019608

Red radioluminescence and radiochemiluminescence: premises for a photodynamic tumour therapy with X-rays and haematoporphyrin derivatives. A working hypothesis.

F Bistolfi1.   

Abstract

In a 1989 paper the author put forward the hypothesis of homogeneously illuminating the interior of the human body with red light by means of X-rays, with a view to extending the possibilities of photodynamic therapy with haematoporphyrin derivatives (HPD). In the present paper, two possible mechanisms for the production of red light by tissues irradiated with X-rays are put forward: a physical mechanism (red radioluminescence) and a physical-chemical mechanism (red radiochemiluminescence). Reactive oxygen metabolites produced in the radiolysis of water, singlet oxygen and lipid peroxidation of biomembranes are the key players in this interesting process. However, before any clinical application can be proposed for integrated tumour therapy (photodynamic therapy with X-rays instead of laser light and haematoporphyrin derivatives), quantitative analyses and experimental research will be required.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11019608

Source DB:  PubMed          Journal:  Panminerva Med        ISSN: 0031-0808            Impact factor:   5.197


  3 in total

1.  Protoporphyrin IX catalyzed hydrogen peroxide to generate singlet oxygen.

Authors:  Jun Zeng; Qiyin Sun; Jihui Su; Jihui Han; Quanshi Zhang; Yuehui Jin
Journal:  Int J Clin Exp Med       Date:  2015-05-15

Review 2.  Nanoscintillator-Mediated X-Ray Induced Photodynamic Therapy for Deep-Seated Tumors: From Concept to Biomedical Applications.

Authors:  Wenjing Sun; Zijian Zhou; Guillem Pratx; Xiaoyuan Chen; Hongmin Chen
Journal:  Theranostics       Date:  2020-01-01       Impact factor: 11.556

Review 3.  Design Principles of Hybrid Nanomaterials for Radiotherapy Enhanced by Photodynamic Therapy.

Authors:  Valeria Secchi; Angelo Monguzzi; Irene Villa
Journal:  Int J Mol Sci       Date:  2022-08-05       Impact factor: 6.208

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.